已核实 DOI PubMed 相关产品: 0

Design, synthesis and biological evaluation of pyranocarbazole derivatives against Alzheimer’s disease, with antioxidant, neuroprotective and cognition enhancing properties

Journal 2022 · IF 5.307 · 发表于 2022 年 10 月 10 日
作者: Yingda Zang,Jingwen Ning,Ke Liu,Meiyu Shang,Caixia Zang,Chuangjun Li,Jie Ma,Xinyi Chen,Jingwei Ma,Gen Li,Yang Yang,Xiuqi Bao,Dan Zhang,Dongming Zhang
阅读全文 在 PubMed 查看

摘要

A series of novel pyranocarbazole alkaloids were designed and synthesized as derivatives of Claulansine F and CZ-7. Some of the compounds showed strong neuroprotective effects and anti-lipid peroxidation capacity. Among these compounds, 10b , introduced leucine at the C-3 position of pyranocarbazole, was the most active in inhibiting the programmed death of SH-SY5Y cells. This compound exhibited stronger free radical scavenging activity than Edaravone. Furthermore, 10b could penetrate the blood–brain barrier (BBB). More importantly, 10b showed a tendency of improvement in learning and memory in the dose range of 10–40 mg/kg. The research on mechanisms indicated that 10b could reduce oxidative stress in the brain of Aβ 25-35 -intoxicated mice, and then improve the cognitive function of Aβ 25-35 -intoxicated mice. Our findings suggest that 10b may be promising for further evaluation as an intervention for Alzheimer’s Disease.